![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:ASAP3-HDAC4 (FusionGDB2 ID:HG55616TG9759) |
Fusion Gene Summary for ASAP3-HDAC4 |
![]() |
Fusion gene information | Fusion gene name: ASAP3-HDAC4 | Fusion gene ID: hg55616tg9759 | Hgene | Tgene | Gene symbol | ASAP3 | HDAC4 | Gene ID | 55616 | 9759 |
Gene name | ArfGAP with SH3 domain, ankyrin repeat and PH domain 3 | histone deacetylase 4 | |
Synonyms | ACAP4|CENTB6|DDEFL1|UPLC1 | AHO3|BDMR|HA6116|HD4|HDAC-4|HDAC-A|HDACA | |
Cytomap | ('ASAP3')('HDAC4') 1p36.12 | 2q37.3 | |
Type of gene | protein-coding | protein-coding | |
Description | arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3ARF6 GTPase-activating proteinArfGAP with SH3 domain, ankyrin repeat and PH domain 3 1centaurin, beta 6development and differentiation enhancing factor-like 1protein up-regulated i | histone deacetylase 4histone deacetylase A | |
Modification date | 20200313 | 20200329 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000336689, ENST00000495646, ENST00000437606, ENST00000449467, | ||
Fusion gene scores | * DoF score | 1 X 1 X 1=1 | 11 X 11 X 4=484 |
# samples | 1 | 11 | |
** MAII score | log2(1/1*10)=3.32192809488736 | log2(11/484*10)=-2.13750352374993 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: ASAP3 [Title/Abstract] AND HDAC4 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | ASAP3(23755056)-HDAC4(240105765), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ASAP3 | GO:0043547 | positive regulation of GTPase activity | 18400762 |
Tgene | HDAC4 | GO:0000122 | negative regulation of transcription by RNA polymerase II | 10869435|16236793 |
Tgene | HDAC4 | GO:0006338 | chromatin remodeling | 18850004 |
Tgene | HDAC4 | GO:0006476 | protein deacetylation | 27708256 |
Tgene | HDAC4 | GO:0016575 | histone deacetylation | 10869435 |
Tgene | HDAC4 | GO:0033235 | positive regulation of protein sumoylation | 17696781 |
Tgene | HDAC4 | GO:0034983 | peptidyl-lysine deacetylation | 18614528 |
Tgene | HDAC4 | GO:0045892 | negative regulation of transcription, DNA-templated | 10869435 |
Tgene | HDAC4 | GO:0070932 | histone H3 deacetylation | 12590135 |
Tgene | HDAC4 | GO:0070933 | histone H4 deacetylation | 12590135 |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Top |
Fusion Gene ORF analysis for ASAP3-HDAC4 |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for ASAP3-HDAC4 |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Top |
Fusion Protein Features for ASAP3-HDAC4 |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:23755056/:240105765) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for ASAP3-HDAC4 |
![]() |
Top |
Fusion Gene PPI Analysis for ASAP3-HDAC4 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for ASAP3-HDAC4 |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for ASAP3-HDAC4 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | C2931817 | Chromosome 2q37 deletion syndrome | 4 | CTD_human;GENOMICS_ENGLAND;ORPHANET | |
Tgene | C0036341 | Schizophrenia | 2 | PSYGENET | |
Tgene | C0005684 | Malignant neoplasm of urinary bladder | 1 | CTD_human | |
Tgene | C0005695 | Bladder Neoplasm | 1 | CTD_human | |
Tgene | C0009171 | Cocaine Abuse | 1 | CTD_human | |
Tgene | C0011570 | Mental Depression | 1 | PSYGENET | |
Tgene | C0011616 | Contact Dermatitis | 1 | CTD_human | |
Tgene | C0020796 | Profound Mental Retardation | 1 | CTD_human | |
Tgene | C0025363 | Mental Retardation, Psychosocial | 1 | CTD_human | |
Tgene | C0162351 | Contact hypersensitivity | 1 | CTD_human | |
Tgene | C0221357 | Brachydactyly | 1 | CTD_human | |
Tgene | C0236736 | Cocaine-Related Disorders | 1 | CTD_human | |
Tgene | C0340543 | Familial primary pulmonary hypertension | 1 | CTD_human | |
Tgene | C0345967 | Malignant mesothelioma | 1 | CTD_human | |
Tgene | C0525045 | Mood Disorders | 1 | PSYGENET | |
Tgene | C0600427 | Cocaine Dependence | 1 | CTD_human | |
Tgene | C0917816 | Mental deficiency | 1 | CTD_human | |
Tgene | C1862102 | BRACHYDACTYLY, TYPE E1 | 1 | CTD_human | |
Tgene | C1969342 | PULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED | 1 | CTD_human | |
Tgene | C1969343 | Pulmonary Hypertension, Primary, Fenfluramine-Associated | 1 | CTD_human | |
Tgene | C3203102 | Idiopathic pulmonary arterial hypertension | 1 | CTD_human | |
Tgene | C3714756 | Intellectual Disability | 1 | CTD_human | |
Tgene | C3714844 | Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia | 1 | CTD_human | |
Tgene | C4552070 | Pulmonary Hypertension, Primary, 1 | 1 | CTD_human |